How Clinical Trials Are Changing Lives

On this special International Clinical Trials Day episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by Professor Chris Fox, Professor of Haematology at Nottingham University Hospitals and Medical Director of the Trials Acceleration Programme (TAP), to discuss the vital role clinical trials play in advancing blood cancer treatment and improving patient outcomes. What’s in this episode: Professor Fox’s journey into haematology and lymphoma, and the differences between lymphoma and leukaemia How he balances patient care with leading and designing clinical trials to bring new treatments to patients Why clinical trials are essential for developing safer and more effective therapies for blood cancers The major advances transforming lymphoma treatment, including immunotherapy, CAR-T cell therapy, and bispecific antibodies The impact of the Trials Acceleration Programme (TAP) in improving access to pioneering clinical trials across the UK Why Professor Fox believes the future of lymphoma treatment is incredibly promising, with continued progress expected over the next decade Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠https://www.cureleukaemia.co.uk/⁠